We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
IndustryPolitics

US Attorney in Massachusetts Will Let Legal Market Proceed

Ben AdlinPublished on July 11, 2018 · Last updated July 28, 2020
Andrew Lelling, U.S. attorney for Massachusetts, raises his hand during his installation as the state's chief federal law enforcement officer, Wednesday, Feb. 21, 2018, at federal court, in Boston. (AP Photo/Steven Senne)

Remember when Jeff Sessions tried to turn the tide against cannabis legalization? Even within his own Justice Department, the bumbling effort by the US attorney general appears to have fallen flat.

On Tuesday, the top federal prosecutor in Massachusetts—the latest state to launch a regulated retail cannabis market, though stores have yet to open—signaled that he plans to let the state’s legalization rollout move forward.

“I will not effectively immunize the residents of the Commonwealth from federal marijuana enforcement,” US Attorney Andrew Lelling, a Trump appointee, said in a statement. “My office’s resources, however, are primarily focused on combatting the opioid epidemic that claims thousands of lives in the Commonwealth each year.”

Pointing to other states that have legalized cannabis for adult use, Lelling said that he anticipates focusing his cannabis enforcement efforts on a few specific areas. These include overproduction, which Lelling said “creates the risk of illegal, and lucrative, marijuana sales to users in nearby states where recreational marijuana use remains illegal,” and targeted sales to minors. Also a target: organized crime and interstate trafficking of drug proceeds.

BREAKING: US Attorney for MA Andrew Lelling releases statement that all but blesses the state’s regulated marijuana industry, saying he’ll focus on overproduction, sales to minors, and organized crime — essentially, the principles of the Cole Memo rescinded by AG Jeff Sessions. pic.twitter.com/37TslEQVFw

— Dan Adams (@Dan_Adams86) July 10, 2018

In his statement, Lelling made it clear that he can’t guarantee that federal prosecutors or law enforcement agents won’t ever take action against state-legal cannabis. But by prioritizing overproduction, diversion, and underage sales—which are prohibited not only at the federal level, but also under state law—Lelling’s office may actually be doing the legal industry a favor, going after bad actors who could tarnish Massachusetts’s nascent legal market.

As Boston Globe cannabis reporter Dan Adams noted, the enforcement priorities also echo those identified in the Cole memo, the Obama-era DOJ policy that Sessions rescinded in early January, at the height of the attorney general’s campaign against state-legal cannabis.

Lelling issued a less committal statement in the immediate aftermath of Sessions’ undoing of the Cole memo. At the time, said he was unable to provide any assurances to participants in the state-legal marijuana trade, calling the matter “a straightforward rule of law issue.”

“Congress has unambiguously made it a federal crime to cultivate, distribute and/or possess marijuana,” Lelling said in the Jan. 8 statement. “As a law enforcement officer in the Executive Branch, it is my sworn responsibility to enforce that law.”

By the end of January, however, Lelling seemed to acknowledge that his office’s limited resources would be put to better use going after illicit opioids rather than state-regulated, voter-approved cannabis. On Jan. 24, he told reporters: “The number one enforcement priority for my office is the opioid crisis.”

“Twenty-one hundred people in Massachusetts were killed by opioid overdoses last year, not marijuana overdoses,” he continued, “so that’s where my resources are going right now.”

Yesterday’s statement seemed to confirm, in writing, the policy that serves the people of Massachusetts without directly pushing back against Sessions—his boss—in Washington DC.Looking for Legal Cannabis in Massachusetts?

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
adult-use cannabisJeff Sessionslaw enforcementlegalizationmassachusetts
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles

The latest in Industry

  • Delivered Inc.: A dispensary at your doorstep image
    Delivered Inc.: A dispensary at your doorstep
    Leafly Staff
  • Green Flash: Delivering Boston’s cannabis future image
    Green Flash: Delivering Boston’s cannabis future
    Leafly Staff
  • Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC image
    Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC
    Leafly Staff
  • America’s top cannabis events of 4/20 2025 image
    America’s top cannabis events of 4/20 2025
    Amelia Williams
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.